News
2021-11-11 12:45
Stockholm, Sweden, iZafe Group AB (publ) ("iZafe" or "the Company") today announced the appointment of Carl-Fredrik Bothén as Chief Marketing Officer. In his new role, Bothén will be an integral part of the executive...
2021-10-21 11:15
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED KINGDOM, THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, HONG KONG, NEW ZEALAND, SWITZERLAND, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH...
2021-10-14 20:05
iZafe Group AB (publ.) (”iZafe” or ”the Company”) announces that the price for the consumer version of Dosell will be SEK 299 per month. Dosell Consumer is a subscription service without binding period or notice period. A subscription...
2021-10-14 09:20
iZafe Group AB (publ.) (“iZafe” or “the Company”) announces the initiation of the launch of Dosell Consumer as an end product to the healthcare service Sempli Farma. Today, 25 pharmacies in Italy have already subscribed to the...
2021-10-13 09:00
iZafe Group AB (publ) (”iZafe” or ”the Company”) announces that they have filed for several completions of their PCT patent application. Thus, the Company enables a greater geographic patent protection, which is part of iZafe’s...
2021-10-12 08:30
iZafe Group AB (publ) (”iZafe” or ”the Company”) announces that Vice Chairman of the Board Göran Hermansson and CEO Anders Segerström are subscribing for an additional of combined 458,000 units in the ongoing rights issue...
2021-10-04 13:55
iZafe Group AB (publ.) announces that Dosell Consumer will be launched on October 18 via Apoteket AB. The first delivery of Dosell Consumer will be sent to Apoteket today, October 4, before the start of sales. In connection with the launch, the media...
2021-09-29 12:50
iZafe Group AB (publ.) announces that for the second year in a row, the Company is one of the nominated entries to win the Golden Pill. iZafe Group participates in the competition with Dosell Consumer - Sweden's first pharmaceutical robot for consumers...
2021-09-24 13:45
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED KINGDOM, THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, HONG KONG, NEW ZEALAND, SWITZERLAND, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH...
2021-09-07 09:25
iZafe Group AB (publ.) announces that their pilot project with consumers now has been completed with a positive result, which paves the way for a successful launch in the Swedish and Italian markets. The test participators in the pilot project have had...
2021-09-06 15:15
iZafe Group AB (publ.) announces the opportunity for shareholders, media, and other stakeholders to ask company-related questions in connection with the publication of the Rights Issue which was communicated by press release today, September 6, 2021...
2021-09-06 08:30
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED KINGDOM, THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, HONG KONG, NEW ZEALAND, SWITZERLAND, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH...
2021-08-31 08:30
Stockholm, Sweden. iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading life science company in the digitalization of medication management has signed an exclusive collaboration agreement with Apoteket AB to introduce the medication...
2021-07-19 12:52
Stockholm, Sweden – iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading Life Science company specializing in healthcare services digitalization announces the opportunity for shareholders, media, and other stakeholders to ask company-related...
2021-07-15 09:45
Erik Gillsbro began his employment at iZafe Group as product owner for Dosell in April 2021. He has had an intensive learning period and has already been maximally involved in the upcoming launch of Dosell Consumer, the development of Dosell 2.0 and the...
2021-07-14 12:00
Stockholm, Sweden. iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading life science company in the digitalization of medication management - updates the market about the pilot project that is now being carried out with consumers to...
2021-06-14 09:00
Stockholm, Sweden. iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading life science company in the digitalization of medication management announces that it has signed a letter of intent with Apoteket AB to investigate the possibilities...
2021-06-10 10:45
Stockholm, Sweden. iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading life science company in the digitalization of medication management announces that it is launching a pilot project with twenty selected people from a group of several...
2021-06-09 14:50
Stockholm, Sweden. iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading life science company in the digitalization of medication management decided in November 2018 on a warrant program, TO 6 B. The exercise period for the warrants of...
2021-06-08 09:45
Stockholm, Sweden. iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading life science company in the digitalization of medication management announces today that the company's pharmaceutical robot Dosell has been registered in the...
2021-05-03 12:00
Stockholm, Sweden. iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading life science company in the digitalization of medication management updates the market on the latest developments of the next generation of Dosell - Dosell 2.0 which...